rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mitchell Gendel

Global General Counsel

Company insider

Files Form 4 as: Global General Counsel, Tilray Brands; General Counsel, Emerald Holding; Gen. Counsel & Corp. Secretary, Stagwell.

In numbers

Trades disclosed
146
Buys
17
Sells
2
Bought
$324K
Sold
$214K
Companies
3
Companies where not an officer
0
First trade
28 Feb 2006
Last trade
26 Aug 2026
Last filed
27 Aug 2026

Companies traded

Where they are an officer
TLRY Tilray BrandsOfficer · Pharmaceuticals · last 26 Aug 20264 buys · 0 sells
Emerald HoldingOfficer · last 1 May 20211 buy · 0 sells
STGW StagwellOfficer · Advertising & Marketing · last 22 Mar 201912 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
26 Aug 2026filed 27 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—50,556 at $0.00filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$131K26,795 at $4.88filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—109,748 at $0.00filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—50,556 at $0.00filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—109,748 at $0.00filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$284K58,167 at $4.88filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—50,556 at $0.00filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—109,748 at $0.00filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—50,556 at $0.00filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$131K26,795 at $4.88filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—109,748 at $0.00filing
26 Aug 2026filed 27 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$284K58,167 at $4.88filing
6 Aug 2026filed 7 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Bought$11K2,500 at $4.43filing
6 Aug 2026filed 7 Aug 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Bought$11K2,500 at $4.43filing
30 Jul 2026filed 31 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—24,379 at $0.00filing
30 Jul 2026filed 31 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—24,379 at $0.00filing
30 Jul 2026filed 31 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$54K12,921 at $4.20filing
30 Jul 2026filed 31 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—24,379 at $0.00filing
30 Jul 2026filed 31 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—24,379 at $0.00filing
30 Jul 2026filed 31 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$54K12,921 at $4.20filing

Sectors

Communications14
Health Care4
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Brandt A. VaughanDirector · Director at Stagwell, filing Form 4 there in the last year
Eli SamahaDirector · Director at Stagwell, filing Form 4 there in the last year
Denise M. FaltischekChief Strategy Officer · Chief Strategy Officer at Tilray Brands, filing Form 4 there in the last year
Carl A. MertonChief Financial Officer · Chief Financial Officer at Tilray Brands, filing Form 4 there in the last year
Irwin D. SimonPresident and CEO · President and CEO at Tilray Brands, filing Form 4 there in the last year
Frank P. LanutoOfficer · Also traded STGW in the last 90 days